-
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells
Zhang, L., Atencia Taboada, L., Baglamis, S., de Kroon, M., Elshout, C., Ramesh, P., Helderman, R. F. C. P. A., Torang, A., Cameron, K., van Driel, M. S., Wouters, V. M., van Neerven, S. M. & Medema, J. P., 1 Dec 2025, In: Oncogenesis. 14, 1, 25.Research output: Contribution to journal › Article* › Academic › peer-review
-
UGT8 mediated sulfatide synthesis modulates BAX localization and dictates apoptosis sensitivity of colorectal cancer
Zhang, L., Ramesh, P., Atencia Taboada, L., Roessler, R., Zijlmans, D. W., Vermeulen, M., Picavet-Havik, D. I., van der Wel, N. N., Vaz, F. M. & Medema, J. P., 2024, (E-pub ahead of print) In: Cell Death and Differentiation.Research output: Contribution to journal › Article* › Academic › peer-review
-
BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer
Ramesh, P., di Franco, S., Atencia Taboada, L., Zhang, L., Nicotra, A., Stassi, G. & Medema, J. P., 15 Feb 2022, In: Cell reports. 38, 7, 110374.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications